2022 Hospital Medicine Summit

Announcing the 2022 Hospital Medicine Summit

Saturday, December 3, 2022

8:00 AM – 1:30 PM EST

Complimentary Live Virtual CE/CME Conference!

Earn up to 5.0 AMA, MOC, ANCC, and ACPE credits!

PROVIDER STATEMENT

This CME activity for ACCME credit is provided by Integrity Continuing Education, Inc.

This CE activity for ANCC and ACPE credit is jointly provided by Global Education Group and Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals, Daiichi Sankyo, Inc., GlaxoSmithKline, and Salix Pharmaceuticals.

EDUCATIONAL PARTNERS

Monmouth-Ocean Medical Society

Philadelphia County Medical Society

PROGRAM OVERVIEW

Since 2015, the Hospital Medicine Summit (HMS), a multidisciplinary educational event, has been providing an exceptional educational experience that is inclusive of clinicians who manage patients in the acute setting and those who have transitioned to the chronic-care setting. Serving hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses, HMS fulfills a critical need to address significant changes in the healthcare system and the increased demand on these clinicians so they can provide optimal care to patients both in the hospital or acute care setting and when they are discharged into the community healthcare system.

TARGET AUDIENCE

This educational activity has been designed to meet the needs of physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists who practice in hospital, internal medicine, and chronic-care settings.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Keynote: Collaborative Care Between Hospital-based Clinicians and Community Specialists

Learning objectives to come

Session 1 – Taking the Kidneys to Heart: Managing CKD-Related Anemia With Emerging HIF-PHIs

Clarify the disease burden imposed by untreated or undertreated anemia in patients with chronic kidney disease (CKD), including in racially diverse populations

Correlate the pathophysiology of anemia in CKD with viable therapeutic targets

Identify appropriate candidates for emerging CKD-related anemia treatments among patients on or not on dialysis based on efficacy and safety data from recent clinical trials

Session 2 – The Role of the Hospitalist: A Focus on Oncology Treatment Adverse Events

Review the associated grade ❤ treatment-related adverse events (trAE) with new and novel anticancer agents

Identify patients presenting with serious trAEs and devise an appropriate management plan